A survey of stereotactic body radiotherapy use in the United States

Stereotactic body radiotherapy (SBRT) is a technique used to deliver high, ablative doses of radiation in a limited number of fractions to ≥1 extracranial target(s). To the authors' knowledge, the prevalence of SBRT use among radiation oncologists in the United States is unknown.

[1]  Robert L. Foote,et al.  Stereotactic Body Radiotherapy in the Treatment of Adrenal Metastases , 2013, American journal of clinical oncology.

[2]  Joshua D. Lawson,et al.  A survey of image‐guided radiation therapy use in the United States , 2010, Cancer.

[3]  Edward Clouser,et al.  Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. , 2010, International journal of radiation oncology, biology, physics.

[4]  A. Martin,et al.  Stereotactic body radiotherapy: a review. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  Mark K Buyyounouski,et al.  Stereotactic body radiotherapy for primary management of early-stage, low- to intermediate-risk prostate cancer: report of the American Society for Therapeutic Radiology and Oncology Emerging Technology Committee. , 2010, International journal of radiation oncology, biology, physics.

[6]  S. Perkins,et al.  Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[7]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[8]  M. Santoro,et al.  Stereotactic body radiotherapy for organ-confined prostate cancer , 2010, BMC urology.

[9]  J. Stoner,et al.  Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations , 2010, Journal of applied clinical medical physics.

[10]  Joshua D. Lawson,et al.  Utilization of advanced imaging technologies for target delineation in radiation oncology. , 2009, Journal of the American College of Radiology : JACR.

[11]  H. Shirato,et al.  Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. , 2009, International journal of radiation oncology, biology, physics.

[12]  J. Friedland,et al.  Stereotactic Body Radiotherapy: An Emerging Treatment Approach for Localized Prostate Cancer , 2009, Technology in cancer research & treatment.

[13]  Lijun Ma,et al.  Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. , 2009, International journal of radiation oncology, biology, physics.

[14]  Fang-Fang Yin,et al.  Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. , 2009, International journal of radiation oncology, biology, physics.

[15]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Toshio Ohashi,et al.  Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. , 2009, International journal of radiation oncology, biology, physics.

[17]  Daniel T Chang,et al.  Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas , 2009, Cancer.

[18]  H. Jang,et al.  Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis , 2008, BMC Cancer.

[19]  Joe Y. Chang,et al.  Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[20]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[21]  P. Balter,et al.  Early Results of Stereotactic Body Radiation Therapy (SBRT) in Centrally/Superiorly Located Stage I or Isolated Recurrent NSCLC , 2008 .

[22]  Dwight E Heron,et al.  Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. , 2008, Clinical lung cancer.

[23]  P. Levendag,et al.  Reduction of respiratory liver tumor motion by abdominal compression in stereotactic body frame, analyzed by tracking fiducial markers implanted in liver. , 2008, International journal of radiation oncology, biology, physics.

[24]  Y. Yamada,et al.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. , 2008, International journal of radiation oncology, biology, physics.

[25]  Sergey Povzner,et al.  Management of three-dimensional intrafraction motion through real-time DMLC tracking. , 2008, Medical physics.

[26]  Steve B. Jiang,et al.  Quality assurance challenges for motion-adaptive radiation therapy: gating, breath holding, and four-dimensional computed tomography. , 2008, International journal of radiation oncology, biology, physics.

[27]  Haoran Jin,et al.  Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. , 2008, International journal of radiation oncology, biology, physics.

[28]  E. Smit,et al.  Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[29]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  I. Lax,et al.  Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney , 2008, Acta oncologica.

[31]  C. Cleeland,et al.  Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. , 2007, Journal of neurosurgery. Spine.

[32]  R. Timmerman,et al.  Stereotactic Body Radiation Therapy: A Comprehensive Review , 2007, American journal of clinical oncology.

[33]  J. Fowler,et al.  Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. , 2007, International journal of radiation oncology, biology, physics.

[34]  Joachim E Wildberger,et al.  Active breathing control (ABC): determination and reduction of breathing-induced organ motion in the chest. , 2007, International journal of radiation oncology, biology, physics.

[35]  William C Welch,et al.  Radiosurgery for Spinal Metastases: Clinical Experience in 500 Cases From a Single Institution , 2007, Spine.

[36]  J. Beitler,et al.  Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. , 2006, International journal of radiation oncology, biology, physics.

[37]  U. Haedinger,et al.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.

[38]  J. Petersen,et al.  Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.

[39]  Sten Nilsson,et al.  Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  Quynh-Thu Le,et al.  Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.

[41]  Cedric X. Yu,et al.  Real-time intra-fraction-motion tracking using the treatment couch: a feasibility study , 2005, Physics in medicine and biology.

[42]  Sonja Dieterich,et al.  CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. , 2005, Journal of neurosurgery. Spine.

[43]  J. Beitler,et al.  Definitive, High-Dose-Per-Fraction, Conformal, Stereotactic External Radiation for Renal Cell Carcinoma , 2004, American journal of clinical oncology.

[44]  Albert C Koong,et al.  Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.

[45]  Y. Shibamoto,et al.  Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. , 2001, International journal of radiation oncology, biology, physics.

[46]  J. Wong,et al.  Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. , 2001, International journal of radiation oncology, biology, physics.

[47]  T Mizowaki,et al.  The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. , 2001, International journal of radiation oncology, biology, physics.

[48]  Issam El Naqa,et al.  Lung STEREOTACTIC BODY RADIATION THERAPY FOR EARLY-STAGE NON – SMALL-CELL LUNG CANCER : THE PATTERN OF FAILURE IS DISTANT , 2010 .

[49]  C. Lawton,et al.  Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial , 2010 .

[50]  W. Franklin,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  L. Gaspar,et al.  Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.

[52]  P. J. Keall,et al.  Potential radiotherapy improvements with respiratory gating , 2009, Australasian Physics & Engineering Sciences in Medicine.

[53]  Steve B. Jiang,et al.  The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.

[54]  F. Lohr,et al.  Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  I. Lax,et al.  Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. , 1994, Acta oncologica.